Progressive elevation of antithrombin III levels during acute lymphoblastic leukemia induction treatment. Not followed by a decrease in antithrombin III after addition of asparaginase: A randomized study between Escherichia coli and Erwinia asparaginase

International Journal of Pediatric Hematology/Oncology

Volumn 3, Issue 1, 1996, Pages 69-74

  Risseeuw Appel, I M ^a   Dekker, I ^a   Stigter, R L ^a   Hop, W C J ^a   Hahlen, K ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; Antithrombin III; Asparaginase

Indexed keywords

ANTIGEN; ANTITHROMBIN III; ASPARAGINASE; BACTERIAL PROTEIN; DAUNORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ERWINIA; ESCHERICHIA COLI; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029995093     PISSN: 10702903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)